Online ISSN: 1945-4589
About Aging
Launched in 2009, Aging publishes papers of general interest and biological significance in all fields of aging research and age-related diseases, including cancer—and now, with a special focus on COVID-19 vulnerability as an age-dependent syndrome. Topics in Aging go beyond traditional gerontology, including, but not limited to, cellular and molecular biology, human age-related diseases, pathology in model organisms, signal transduction pathways (e.g., p53, sirtuins, and PI-3K/AKT/mTOR, among others), and approaches to modulating these signaling pathways.

Aging | IGF1 gene therapy in middle-aged female rats delays reproductive senescence through its effects on hypothalamic GnRH and kisspeptin neurons

Aging

November 15, 2022
PRESS RELEASE: A new research paper was published as the cover for Aging's Volume 14, Issue 21, entitled, “IGF1 gene therapy in middle-aged female rats delays reproductive senescence through its effects on hypothalamic GnRH and kisspeptin neurons.” continue reading »

Aging | Age-associated changes in microglia activation and Sirtuin-1- chromatin binding patterns

News

November 10, 2022
PRESS RELEASE: A new research paper was published in Aging's Volume 14, Issue 20, entitled, “Age-associated changes in microglia activation and Sirtuin-1- chromatin binding patterns.” continue reading »

Aging | Lamin A to Z in normal aging

Aging

November 9, 2022
PRESS RELEASE: A new research perspective was published in Aging's Volume 14, Issue 20, entitled, “Lamin A to Z in normal aging.” continue reading »

Aging’s Scientific Integrity Process

Aging

November 8, 2022
The open-access journal Aging recently launched a new webpage showcasing the full Aging Scientific Integrity Process. continue reading »

Aging | Rapamycin treatment early in life reprograms aging: hyperfunction theory and clinical practice

Aging

November 3, 2022
PRESS RELEASE: A new research perspective was published on October 24, 2022, in Aging's Volume 14, Issue 20, entitled, “Rapamycin treatment early in life reprograms aging: hyperfunction theory and clinical practice.” continue reading »